Sino Biopharmaceutical Limited (1177.HK)
HKD 3.25
(1.25%)
HKD 3.25
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.06 Billion | 6.26 Billion | 5.36 Billion | 5.32 Billion | 5.32 Billion | 5.09 Billion |
| Net Income | 5.93 Billion | 5.77 Billion | 18.57 Billion | 5.01 Billion | 5.58 Billion | 11.42 Billion |
| Depreciation & Amortization | 1.07 Billion | 1.04 Billion | 992.55 Million | 1.65 Billion | 1.46 Billion | 1.17 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 18.12 Million | 29.72 Million | - | - | - | - |
| Change in working capital | -430.51 Million | -195.59 Million | -339.13 Million | 261.33 Million | -278.65 Million | 243.29 Million |
| Other non-cash items | 287.91 Million | -394.56 Million | -13.85 Billion | -1.6 Billion | -1.44 Billion | -7.75 Billion |
| Investing Cash Flow | -756.97 Million | -4.07 Billion | -2.51 Billion | -7.84 Billion | -3.82 Billion | -616.1 Million |
| Investments in PPE | -1.7 Billion | -1.7 Billion | -1.89 Billion | -1.85 Billion | -1.73 Billion | -1.69 Billion |
| Acquisitions | -742.7 Million | -58.52 Million | -958.7 Million | -4.19 Billion | -221.66 Million | 1.2 Billion |
| Investment purchases | -1.65 Billion | -4.48 Billion | -4.84 Billion | -7.16 Billion | -2.89 Billion | -2.45 Billion |
| Sales/Maturities of investments | 2.56 Billion | 1.07 Billion | 903.24 Million | 5.12 Billion | 914.26 Million | 2.16 Billion |
| Other Investing Activities | -8.74 Million | 1.09 Billion | 4.28 Billion | 250.4 Million | 111.82 Million | 160.03 Million |
| Financing Cash Flow | -6.54 Billion | -3.18 Billion | -3.22 Billion | 2.23 Billion | 2.8 Billion | -2.17 Billion |
| Debt repayment | -1.71 Billion | -8.7 Billion | -2.82 Billion | -1.76 Billion | -3.19 Billion | -93.81 Million |
| Dividends payments | -632.66 Million | -1.26 Billion | -938.48 Million | -1.18 Billion | -819.68 Million | -710.32 Million |
| Common Stock Repurchased | -396.39 Million | -867.61 Million | -332.93 Million | -195.37 Million | -32.05 Million | -604.41 Million |
| Common Stock Issuance | - | - | 732.8 Million | 5.35 Billion | 6.82 Billion | -796.73 Million |
| Other Financing Activities | -63.52 Million | 7.65 Billion | 140.16 Million | 18.17 Million | 28.33 Million | 27.56 Million |
| Accounts receivables | -816.02 Million | -421.65 Million | -1.3 Billion | -198.78 Million | 196.3 Million | -436.2 Million |
| Accounts payables | - | 421.65 Million | 1.3 Billion | 198.78 Million | -196.3 Million | - |
| Inventory | 135.32 Million | -391.1 Million | -57.47 Million | -221.45 Million | -449.43 Million | -102.16 Million |
| Other working capital | 108.21 Million | 195.5 Million | -281.66 Million | 482.78 Million | 170.78 Million | 345.45 Million |
| Cash at beginning of period | 8.65 Billion | 9.59 Billion | 10.62 Billion | 10.63 Billion | 6.23 Billion | 3.69 Billion |
| Cash at end of period | 7.5 Billion | 8.65 Billion | 9.59 Billion | 10.62 Billion | 10.63 Billion | 6.23 Billion |
| Capital Expenditure | -1.7 Billion | -1.7 Billion | -1.89 Billion | -1.85 Billion | -1.73 Billion | -1.69 Billion |
| Effect of forex changes on cash | 90.52 Million | 47.32 Million | -649.71 Million | 280.01 Million | 95.05 Million | 242.46 Million |
| Net cash flow / Change in cash | -1.14 Billion | -944.73 Million | -1.02 Billion | -7.01 Million | 4.39 Billion | 2.54 Billion |
| Free Cash Flow | 4.36 Billion | 4.55 Billion | 3.47 Billion | 3.46 Billion | 3.59 Billion | 3.4 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.5 Billion | 1.5 Billion | 5.93 Billion | - | 629.39 Million | 629.39 Million |
| Depreciation & Amortization | 255.11 Million | 255.11 Million | 1.07 Billion | - | 326.6 Million | 326.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 18.12 Million | - | - | - |
| Change in working capital | - | - | -430.51 Million | - | - | - |
| Other non-cash items | -224.45 Million | -224.45 Million | 287.91 Million | - | 379.56 Million | 379.56 Million |
| Investing Cash Flow | -1.02 Billion | -1.02 Billion | -756.97 Million | - | -2.03 Billion | -2.03 Billion |
| Investments in PPE | -203.74 Million | -203.74 Million | -1.7 Billion | - | -376.95 Million | -376.95 Million |
| Acquisitions | - | - | -742.7 Million | - | 229 Thousand | 229 Thousand |
| Investment purchases | - | - | -1.65 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 2.56 Billion | - | - | - |
| Other Investing Activities | -816.71 Million | -816.71 Million | -8.74 Million | - | -1.66 Billion | -1.66 Billion |
| Financing Cash Flow | -2.04 Billion | -2.04 Billion | -6.54 Billion | - | -2.02 Billion | -2.02 Billion |
| Debt repayment | - | - | -1.71 Billion | - | - | - |
| Dividends payments | - | - | -632.66 Million | - | - | - |
| Common Stock Repurchased | -180.77 Million | -180.77 Million | -396.39 Million | - | -117.85 Million | -117.85 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.86 Billion | -1.86 Billion | -63.52 Million | - | -1.9 Billion | -1.9 Billion |
| Accounts receivables | - | - | -816.02 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 135.32 Million | - | - | - |
| Other working capital | - | - | 108.21 Million | - | - | - |
| Cash at beginning of period | - | - | 8.65 Billion | 3.29 Billion | - | - |
| Cash at end of period | -1.51 Billion | -1.51 Billion | 7.5 Billion | 3.29 Billion | -2.68 Billion | -2.68 Billion |
| Capital Expenditure | -203.74 Million | -203.74 Million | -1.7 Billion | - | -376.95 Million | -376.95 Million |
| Effect of forex changes on cash | 13.13 Million | 13.13 Million | 90.52 Million | - | 42.41 Million | 42.41 Million |
| Net cash flow / Change in cash | -1.51 Billion | -1.51 Billion | -1.14 Billion | - | -2.68 Billion | -2.68 Billion |
| Free Cash Flow | 1.33 Billion | 1.33 Billion | 4.36 Billion | - | 958.6 Million | 958.6 Million |
1635
WMUU
LCR
MTTCF
RDRB
REDTAPE